Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Der Internist|August 16, 2021
[Tumor vaccination-strategies and time points]Yacine Maringer, Juliane S Walz
Cancers|October 14, 2022
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease OutcomeMaddalena Marconato, Yacine Maringer, Juliane S Walz, et al.
Viruses|March 30, 2023
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID SyndromeChristopher Hackenbruch, Yacine Maringer, Christian M Tegeler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 16, 2022
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohortChristian M Tegeler, Tatjana Bilich, Yacine Maringer, et al.
Science Immunology|November 1, 2022
Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccinationYacine Maringer, Annika Nelde, Sarah M Schroeder, et al.
Human Molecular Genetics|January 22, 2020
Calpain-1 ablation partially rescues disease-associated hallmarks in models of Machado-Joseph diseaseJonasz J Weber, Eva Haas, Yacine Maringer, et al.
Frontiers in Oncology|October 29, 2024
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patientsSusanne Jung, Annika Nelde, Yacine Maringer, et al.
Frontiers in Oncology|September 10, 2024
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimensAlexander Englisch, Clara Hayn, Susanne Jung, et al.
Molecular Neurobiology|October 30, 2021
A Novel SCA3 Knock-in Mouse Model Mimics the Human SCA3 Disease Phenotype Including Neuropathological, Behavioral, and Transcriptional Abnormalities Especially in OligodendrocytesEva Haas, Rana D Incebacak, Thomas Hentrich, et al.
Frontiers in Immunology|July 26, 2021
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic LeukemiaAnnika Nelde, Yacine Maringer, Tatjana Bilich, et al.
Pageof 3